Dr. Reddy's ( RDY ) , Kainomyx Sign Potential Deal for Malaria Drug
Dr. Reddy's (RDY) is gearing up to potentially collaborate with Kainomyx to jointly develop an affordable anti-malarial drug.
| Ticker |
Sentiment |
Impact |
|
ARCT
|
Somewhat Bullish
|
34 %
|
|
ILMN
|
Somewhat Bullish
|
23 %
|
|
HLN
|
Neutral
|
17 %
|
